Previously, LUTN prevents the progression of liver fibrosis induced by carbon tetrachloride-(CCL4) through targeting AKT/mTOR/p70S6K and TGFβ/Smad signaling pathways [26]. The gene discussed is AKT1; the disease is Hepatic fibrosis.